Results 1 to 10 of about 76,927 (233)

Carbohydrate—protein conjugate vaccines [PDF]

open access: yesClinical Microbiology and Infection, 2003
Various pathogenic bacteria have coats of polysaccharide, many with repeating epitopes. Though polysaccharide vaccines have been available for some time, they induce mainly IgM production, and are only moderately protective in adults and ineffective in ...
Ada, G., Isaacs, D.
core   +6 more sources

Development of a novel glycoengineering platform for the rapid production of conjugate vaccines [PDF]

open access: yesMicrobial Cell Factories, 2023
Conjugate vaccines produced either by chemical or biologically conjugation have been demonstrated to be safe and efficacious in protection against several deadly bacterial diseases.
Sherif Abouelhadid   +15 more
doaj   +2 more sources

Conjugate vaccines [PDF]

open access: bronzeClinical and Experimental Immunology, 2000
David Goldblatt
openalex   +5 more sources

Evaluation of the Induction of Immune Memory following Infant Immunisation with Serogroup C Neisseria meningitidis Conjugate Vaccines - Exploratory Analyses within a Randomised Controlled Trial [PDF]

open access: yes, 2014
Aim: We measured meningococcal serogroup C (MenC)-specific memory B-cell responses in infants by Enzyme-Linked Immunospot (ELISpot) following different MenC conjugate vaccine schedules to investigate the impact of priming on immune memory.
Birks, Jacqueline   +7 more
core   +20 more sources

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines

open access: yesFrontiers in Molecular Biosciences, 2023
Vaccines are cost-effective tools for reducing morbidity and mortality caused by infectious diseases. The rapid evolution of pneumococcal conjugate vaccines, the introduction of tetravalent meningococcal conjugate vaccines, mass vaccination campaigns in ...
Francesca Micoli   +4 more
doaj   +1 more source

Vaccines against Meningococcal Diseases

open access: yesMicroorganisms, 2020
Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening conditions. Thanks to advancements in vaccine development, vaccines are now available for five out of six meningococcal disease-causing serogroups (A, B, C, W,
Mariagrazia Pizza   +2 more
doaj   +1 more source

On the mechanisms of conjugate vaccines [PDF]

open access: yesProceedings of the National Academy of Sciences, 2018
During the last three decades, the development and commercialization of conjugate vaccines against Haemophilus influenzae type b (Hib), pneumococcus, and serogroups C, A, W, and Y of meningococcus contributed to the virtual elimination of bacterial meningitis caused by the bacteria included in the vaccines and to the prevention of diseases that used to
Rino Rappuoli   +2 more
openaire   +3 more sources

Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Given increased global concern about vaccine hesitancy, this study estimates coverage of mandatory vs non-mandatory vaccines in children, and assesses whether vaccine hesitancy among young parents relates to their childʻs eventual vaccination status in ...
Mengdi Ji   +3 more
doaj   +1 more source

A Vaccine Against Group B Streptococcus: Recent Advances [PDF]

open access: yes, 2020
Group B streptococcus (GBS) causes a high burden of neonatal and infant disease globally. Implementing a vaccine for pregnant women is a promising strategy to prevent neonatal and infant GBS disease and has been identified as a priority by the World ...
Carreras-Abad, C   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy